Summer Street Affirms Netural Rating on Gilead (GILD); Early Sovoldi Buy-In May Produce Softer Results

February 5, 2014 9:35 AM

Summer Street is still Neutral on Gilead Sciences (Nasdaq: GILD) following Q4 results reported Tuesday night.

Analyst Carol Werther ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found